Compare QTRX & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | WALD |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.0M | 246.7M |
| IPO Year | 2017 | 2021 |
| Metric | QTRX | WALD |
|---|---|---|
| Price | $6.36 | $1.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $11.33 | $4.30 |
| AVG Volume (30 Days) | ★ 793.2K | 67.4K |
| Earning Date | 03-16-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $130,203,000.00 | ★ $274,560,000.00 |
| Revenue This Year | N/A | $2.69 |
| Revenue Next Year | $28.28 | $10.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.22 |
| 52 Week Low | $4.05 | $1.45 |
| 52 Week High | $9.10 | $3.63 |
| Indicator | QTRX | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 53.63 |
| Support Level | $6.29 | $1.50 |
| Resistance Level | $6.85 | $1.85 |
| Average True Range (ATR) | 0.50 | 0.15 |
| MACD | -0.09 | 0.05 |
| Stochastic Oscillator | 14.46 | 71.35 |
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.